Navigation Links
Lightning Strikes Deadliest in Summer

Lightning strikes were responsible for 47 confirmed deaths and 246 confirmed injuries last year, according to the National Oceanic and Atmospheric Administration , and summer is the peak season for lightning-related injuries.

The Fourth of July is a particularly deadly time because so many people are outdoors, says Dr. Mary Ann Cooper, professor of emergency medicine and director of the lightning injury research program at the University of Illinois at Chicago. Most people seriously underestimate the risk of being struck by lightning and do not know when or where to take shelter.

"Decisions about lightning safety must be made by the individual, but education can help people reduce their chances of being struck by lightning," Cooper said.

"Even though the vast majority of those struck by lightning survive, they frequently have permanent after effects, which can include chronic pain, brain injury and thought-processing problems," said Cooper, considered by many to be the leading international expert on lightning strike injuries.

Here are some safety tips to help protect yourself from lightning strikes, courtesy of Cooper, NOAA and the National Weather Service.

"When planning outdoor activities, know what shelter is available and where to go if you hear thunder," Cooper said. When you hear thunder, go indoors immediately. Head for a house, school or large building.

"The rule is, 'when thunder roars, go indoors,'" Cooper said. If you can't get indoors, get into a hardtop car, bus or truck. Never go under a tree.

Stay off phones, computers and video games. "Surprisingly, hard-wired phone use is the leading cause of indoor lightning injuries in the United States," Cooper said. Cell phones are quite safe, aside from distracting someone from seeking safety.

Lightning can hurt you even before it begins to rain and can strike as far as 10 miles away from the rain are
'"/>




Page: 1 2

Related medicine news :

1. Lightning Kicks Up a Furore in the Mobile Industry
2. Now, Cellphones That Alert Against Impending Lightning Strikes
3. Dr Reddy’s Strikes Deal With Rheoscience For Type 2 Diabetes Dru
4. Polio Strikes Again
5. Chikungunya Strikes Chennai, India
6. New Research Suggests That Obesity Strikes Faster Growing Kids
7. Research for Back Pain Relief Strikes Gold
8. Polio Strikes Again in Delhi
9. Government Strikes Right Balance with PBS Reform
10. Stroke Due to Inherited Reasons Strikes Women More
11. Super Bug Strikes Again, Many Deaths Reported
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Lightning Strikes Deadliest Summer

(Date:8/29/2008)...INGTON, Aug. 29 /PRNewswire-USNewswire/ -- The fol...nt, Campaign for Tobacco-Free Kids:, For the seco...s had to,withdraw sponsorship and promotion of a c...international criticism for engaging in cigarette,...hilip Morris International has been forced to with...
(Date:8/29/2008)... First Walkathon to Benefit Muscu...Iselin, NJ (PRWEB) August 29, 2008 -- Students, fa...rd-Brown Iselin] (SBI), in New Jersey, raised $11,...r walkathon, last week. Proceeds from the event a...org [Ryan,s Quest]. The all-volunteer event was a...
(Date:8/29/2008)...WOOD, Ill., Aug. 29 /PRNewswire-FirstCall/ -- Land...ard of Directors declared a regular,quarterly cash...r of fiscal,2008. The dividend will be paid on Oct...er 12, 2008., About Landauer, Landauer is the le...,occupational and environmental radiation exposure...
(Date:8/29/2008)...oston Scientific obligation reduced from $250 to $...rstCall/ -- Boston Scientific,Corporation (NYSE: ... of,Marshall, Texas found two patents of Medtronic... conduct during the prosecution of the patents,bef..., A jury had previously found that certain Boston...
Breaking Medicine News(10 mins):Health News:Philip Morris International Forced to Drop Another Concert Sponsorship; Philippines Health Department Applauded for Taking Action 2Health News:Sanford-Brown Institute - Iselin Raises $11,000 for Ryan's Quest 2Health News:Court Rejects Two Medtronic Patents 2Health News:Court Rejects Two Medtronic Patents 3
...ksburg: Procter & Gamble and the Industrial Design...mpetitive grant of $40,000 to a Virginia Tech team...ollege of Architecture and Urban Affairs for the d... that can add more value to the lives of elderly p...
...uala Lumpur, Malaysia a two-year-old boy dies at t...symptoms of the hand, foot and mouth disease (HFMD...laysia. Totally the disease has killed about eight...he boy. The child hailing from the town of Kapit...
...ersity of Cincinnati (UC) researchers revealed tha...ual characteristics have higher risk for depressiv...f data through surveys which said that the risk fo...eater among respondents who reported negative reli...
...e Minister Manmohan Singh set up a task force to f...of doctors, nurses and lab technicians. The recrui...an opportunity to the unemployed. The move is bas...port submitted by National Commission on Macroecon...
Other Medicine News:
(Date:8/27/2008)...prednisone arm demonstrated a, significant surviv...se -, CAMBRIDGE, Mass., Aug. 27 /- M...nced the publication of results from the 682,patie...eek,s edition of the,New England Journal of Medici...fit and a 30 percent complete remission (CR) rate ...
(Date:8/27/2008)...al, expected by mid-2009 - - Data from second Pha...CKVILLE, Md., Aug. 27 /- Hu...nnounced it has completed enrollment,and initial d... 3,randomized clinical trials of LymphoStat-B(R) (...erythematosus (SLE). Belimumab is being developed ...
(Date:8/26/2008)...mafore Pharmaceuticals Inc.,presented data at the ...es,in Cancer in Washington, D.C., announcing the d... that demonstrate significant anticancer,activity ...molecular scaffold has been developed using,comput...3 kinase inhibitors,as well as isoform-selective s...
(Date:8/26/2008)...FirstCall/ -- XTENT, Inc.,(Nasdaq: XTNT ) today a...,from the CUSTOM II trial was published in the mos...ntervention. The lead author of the article was,Dr...nter Utrecht, Utrecht,The Netherlands on behalf o...es across Europe., The one-year CUSTOM II trial, ...
Breaking Medicine Technology:New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 2New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 4New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 5New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 6Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4Older Americans are more socially engaged than many people may think 16988 1Older Americans are more socially engaged than many people may think 16988 2Older Americans are more socially engaged than many people may think 16988 3Is there anybody out there 3F 2916 1Is there anybody out there 3F 2916 255 Year Old Grandmother to Document Journey of Running Seven Marathons on Seven Continents on Run7on7 com 16984 155 Year Old Grandmother to Document Journey of Running Seven Marathons on Seven Continents on Run7on7 com 16984 255 Year Old Grandmother to Document Journey of Running Seven Marathons on Seven Continents on Run7on7 com 16984 3MEDEX Global Group Hires Industry Veteran Mike Roban as Vice President of Sales 16980 1MEDEX Global Group Hires Industry Veteran Mike Roban as Vice President of Sales 16980 2
...of Peregrine,s,Unique Selective Anti-VEGF Antibodi...l Cancer Models, TUSTIN, Calif., April 20, 2007 /P... Inc. , a clinical stage,biopharmaceutical company... treatment of cancer and hepatitis C virus infecti... presented at the recent,Centennial Annual Meeting...
...Rx Corporation,(NASDAQ:CYTR) today announced that ...clusively licensed to its majority-owned,subsidiar...,published in the April 2007 issue of peer-reviewe...hnology was developed by RXi,Co-founder, Scientifi...setts Medical School (UMMS) Professor of Biochemis...
Other Medicine Technology:Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 2Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 3Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 4Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 5Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 6Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 7CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 2CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 3CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 4
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
Medicine Products: